Permanente Medicine
Home | Contact

Suma Vupputuri, PhD, MPH, FAHA

Research Scientist III

Suma.Vupputuri@kp.org

Education:

PhD, Tulane University School of Public Health and Tropical Medicine, 2001
MPH, Tulane University School of Public Health and Tropical Medicine, 1996

Suma Vupputuri is an epidemiologist with a focus on the etiology, prevention, and treatment of chronic disease. Her substantive areas of interest include heart disease, diabetes, and chronic kidney disease epidemiology, as well as health services and health disparities research. Dr. Vupputuri has worked at Kaiser Permanente for over 10 years in both the Mid-Atlantic and Georgia regions and has experience with many types of study designs including observational, qualitative, pragmatic trials, and multi-site surveillance/data systems.

Dr. Vupputuri has worked in a variety of different health research settings and has broad experience on how real-world health data is collected, managed, and processed in and across different systems. Her goal is to apply her research interests and experiences with “big data” to novel and exciting studies that will ultimately lead to better health outcomes for patients at KPMAS.

Dr. Vupputuri is an elected Fellow of the American Heart Association (FAHA) conferred by the Council on Epidemiology and Prevention and recognized for her excellence and sustained contributions to scholarship, practice, education, and volunteer service within in the American Heart Association. She has 23+ years of research experience; has published 100 manuscripts in peer-reviewed journals; and served as PI/site-PI/co-PI on more than 30 funded studies.

Research Interests:

Chronic disease epidemiology (cardiovascular disease, diabetes, chronic kidney disease), health services, health disparities, comparative effectiveness, medication adherence, quality of care issues

For a full list of publications, please see Dr. Vupputuri’s Curriculum Vitae.

Recent Publications

  1. Anike O, Zhang Q, Bhasin S, Flanders W, Getahun D, Haw J, Huybrechts K, Lash T, McCracken C, Roblin D, Silverberg M, Suglia S, Tangpricha V, Vupputuri S, Goodman M. “Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study.” The Journal of Clinical Endocrinology & Metabolism. 30 May 2024; https://doi.org/10.1210/clinem/dgae353
  2. Awidi A, Woreta F, Sabit A, Hu H, Potu N, Devience E, Wang J, Vupputuri S. “The Effect of Racial/Ethnic and Socioeconomic Differences on Visual Impairment Prior to Cataract Surgery.” Ophthalmology. 19 July 2024. DOI:https://doi.org/10.1016/j.ophtha.2024.07.021
  3. Clennin M, Reifler L, Goodman O, Brown M, Vupputuri S, Daugherty S, Schootman M. “Association of Housing Instability with Obesity Status Among Insured Adults.” Am J Prev Med. 2024 Apr 20:S0749-3797(24)00135-1. doi: 10.1016/j.amepre.2024.04.008.
  4. Pampati S, Dana Flanders W, Zhang Q, Ahmedani BK, Bhasin S, Getahun D, Lash TL, McCracken C, Sandberg DE, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. “Prevalence of self-inflicted injuries among transgender and gender diverse adolescents and young adults compared to their peers: an examination of interaction with mental health morbidity.” Ann Epidemiol. 2023 May;81:40-46.e2.
  5. Genelin M, Helmkamp L, Steiner J, Maertens J, Hanratty R, Vupputuri S, Havranek E, Dickinson L, Blair I, Daugherty S. “Patient Pill Organization Strategies and Adherence Measured in a Cross-Sectional Study of Hypertension.” Patient Prefer Adherence 2023 Mar 23;17:817-826.
  6. Gust C, Bryan A, Havranek E, Vupputuri S, Steiner J, Blair I, Hanratty R, Daugherty S. “Health Behavior Theory and Hypertension Management: Comparisons Among Black Americans, White Americans, and American Indians and Alaska Natives.” Race Soc Probl. 2022 Dec;14(4):369-382.
  7. Lam J, Leyden W, Leong T, Horberg M, Reynolds K, Ambrosy A, Avula H, Hechter R, Towner W, Vupputuri S, Go A, Silverberg M. “Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection.” J Acquir Immune Defic Syndr. 2022 Oct 1;91(2):175-181.
  8. Goodman M, Yacoub R, Getahun D, McCracken C, Vupputuri S, Lash T, Roblin D, Contreras R, Cromwell L, Gardner MD, Hoffman T, Hu H, Im TM, Prakash Asrani R, Robinson B, Xie F, Nash R, Zhang Q, Bhai SA, Venkatakrishnan K, Stoller B, Liu Y, Gullickson C, Ahmed M, Rink D, Voss A, Jung HL, Kim J, Lee P, Sandberg D. “Cohort profile: pathways to care among people with disorders of sex development (DSD).” BMJ Open. 2022 Sep 21;12(9):e063409
  9. Henderson K, Helmkamp L, Steiner J, Havranek E, Vupputuri S, Hanratty R, Blair I, Maertens J, Dickinson M, Daugherty S. “Social Vulnerabilities to Disparities and Participant Attrition: Findings from the Hypertension and VALUES (HYVALUE) Trial.” 2022 May;15(5):e007709
  10. Yishak A, Rubenstein K, Clark E, Bhatia M, Vupputuri S. “Early Referral, Living Donation, and Preemptive Kidney Transplant.” Transplant Proc. 2022 Apr;54(3):615-621.
  11. Islam N, Zhang A, Panagiotakopoulos L, Jean-Pierre T, Bhasin S, Getahun D, Haw JS, McCracken C, Silverberg M, Tangpricha V, Vupputuri S, Goodman M. “Prevalence and Incidence of Type 2 Diabetes Mellitus among Transgender Persons: A Cohort Study.” J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1549-e1557.
  12. Go A, Reynolds K, Avula H, Towner W, Hechter R, Horberg M, Vupputuri S, Leong T, Leyden W, Harrison T, Lee KK, Sung S, Silverberg M. HIV Infection and Variation in Heart Failure Risk by Age, Gender and Ethnicity: The HIV HEART Study. Mayo Clin Proc. 2022 Mar;97(3):465-479.
  13. Kaplan R, Martin K, Tanaka Y, Passman R, Fine M, Rasmussen-Torvik L, Vupputuri S, Khan S. “Efficacy and Safety of Direct Oral Anticoagulant Use for Atrial Fibrillation Across Body Mass Index Categories.” J AmHeart Assoc. 2020 Dec 15;9(24):e017383
  14. Daugherty S, Helmkamp L, Vupputuri S, Hanratty R, Steiner J, Blair I, Dickinson M, Maertens J, Havranek E. “Values Affirmation to Reduce Racial Differences in Medication Adherence: Results of the Multicenter Randomized HYpertension and VALUEs (HYVALUE) Clinical.” JAMA Netw Open. 2021 Dec 1;4(12):e2139533.
  15. Avula H, Ambrosy A, Silverberg M, Reynolds K, Towner W, Hechter R, Horberg M, Vupputuri S, Leong T, Leyden W, Harrison T, Lee K, Sung S, Go A. “HIV Infection and Risks of Morbidity and Death in Adults with Incident Heart.” Eur Heart J Open. 2021 Dec 1;1(3):oeab040
  16. Rahman VJ, Horberg MA, Hu H, Vupputuri S. Implementation of a Plant-Based, Nutrition Program in a Large Integrated Health Care System: Results of a Pilot Program. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211053198.
  17. Wagner S, Panagiotakopoulos L, Nash R, Bradlyn A, Getahun D, Lash TL, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Progression of Gender Dysphoria in Children and Adolescents: A Longitudinal Study. Pediatrics. 2021 Jul;148(1):e2020027722.
  18. Zhang Q, Rechler W, Bradlyn A, Flanders WD, Getahun D, Lash TL, McCracken C, Nash R, Panagiotakopoulos L, Roblin D, Sandberg DE, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Changes in Size and Demographic Composition of Transgender and Gender Non-Binary Population Receiving Care at Integrated Health Systems. Endocr Pract. 2021 May;27(5):390-395.
  19. Vupputuri S, Daugherty S, Yu K, Derus AJ, Wells A, Truong C, Singh T, Emanuel EW. The Quality of Transgender Patient Care: Results from Patient Focus Groups and Electronic Medical Record Data. Healthcare (Basel). 2021 May 2;9(5):530.
  20. Panagiotakopoulos L, Wagner S, Nash R, Bradlyn AS, Getahun DT, Lash TL, Roblin DW, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Pathway from Gender Diverse Behavior to Gender Dysphoria-Related Diagnosis and Hormone Therapy. Pediatrics. 2021 Jul;148(1):e2020027722.
  21. Hashemi L, Zhang Q, Getahun D, Jasuja GK, McCracken C, Pisegna J, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Longitudinal changes in Liver Enzyme Levels among Transgender People Receiving Gender Affirming Hormone Therapy. J Sex Med. 2021 Sep;18(9):1662-1675.
  22. Kaplan RM, Martin K, Tanaka Y, Passman RS, Fine M, Rasmussen-Torvik LJ, Vupputuri S, Khan SS. Efficacy and Safety of Direct Oral Anticoagulant Use for Atrial Fibrillation Across Body Mass Index Categories. J Am Heart Assoc. 2020 Dec 15;9(24):e017383.
  23. Vupputuri S, Daugherty S, Yu K, Truong C, Wells A, Emanuel EW. The quality of care of transgender and gender nonconforming patients: The provider perspective. Perm J. 2020;25:19.227.
  24. Bavishi A, Bruce M, Hongyan N, Mehta PP, Glynn P, Ahmad FS, Yancy CW, Shah SJ, Allen NB, Vupputuri S, Rasmussen-Torvik LJ, Lloyd-Jones DM, Khan SS. Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort. Circ Heart Fail. 2020 Nov;13(11):e007462. Epub 2020 Oct 23.
  25. Rethy L, McCabe M, Pool L, Vu TH, Kershaw K, Yancy C, Vupputuri S, Feinglass J, and Khan S. Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State. Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e007014. Epub 2020 Nov 12.
  26. Kamineni A, Vupputuri S. Challenges to Evaluating Diversity and Inclusion in Scientific Communities (Letter). Am J Epidemiol. 2020 Oct 1;189(10):1210.
  27. To M, Zhang Q, Bradlyn A, Getahun D, Giammattei S, Nash R, Owen-Smith A, Roblin D, Silverberg M, Tangpricha V, Vupputuri S, Goodman M. Visual Conformity with Gender Identity: Its Distribution and Association with Depression and Anxiety in a Cohort of Transgender People. J Sex Med. 2020 Oct;17(10):2084-2092. Epub 2020 Aug 15.
  28. Mak J, Shires DA, Prieto L, Ahmedani BK, Becerra-Culqui TA, Bradlyn A, Flanders WD, Getahun D, Giammattei SV, Hunkeler E, Lash TL, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Slovis J, Tangpricha V, Vupputuri S, Goodman M. Incidence and Determinants of Suicide Attempts in a Cohort of Transgender and Gender Non-Conforming People. Am J Prev Med. 2020 Oct;59(4):570-577.
  29. Kaplan R, Martin K, Tanaka Y, Passman R, Fine M, Rasmussen-Torvik L, Vupputuri S, Khan S. “Efficacy and Safety of Direct Oral Anticoagulant Use for Atrial Fibrillation Across Body Mass Index Categories.” J Am Heart Assoc. 2020 Dec 15;9(24):e017383.
  30. Vupputuri S, Daugherty S, Yu K, Truong C, Wells A, Emanuel E. “The quality of care of transgender and gender nonconforming patients: The provider perspective.” Perm J 2020;25:19.227.
  31. Bavishi A, Bruce M, Hongyan N, Mehta P, Glynn P, Ahmad F, Yancy CW, Shah S, Allen N, Vupputuri S, Rasmussen-Torvik L, Lloyd-Jones D, Khan S. “Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort.” Circ Heart Fail. 2020 Nov;13(11):e007462. Epub 2020 Oct 23.
  32. Rethy L, McCabe M, Pool L, Vu T, Kershaw K, Yancy C, Vupputuri S, Feinglass J, and Khan S. “Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State.” Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e007014. Epub 2020 Nov 12.
  33. Kamineni A, Vupputuri S. “Challenges to Evaluating Diversity and Inclusion in Scientific Communities (Letter). Am J Epidemiol. 2020 Oct 1;189(10):1210.
  34.  To M, Zhang Q, Bradlyn A, Getahun D, Giammattei S, Nash R, Owen-Smith A, Roblin D, Silverberg M, Tangpricha V, Vupputuri S, Goodman M. “Visual Conformity with Gender Identity: Its Distribution and Association with Depression and Anxiety in a Cohort of Transgender People.” J Sex Med. 2020 Oct;17(10):2084-2092. Epub 2020 Aug 15.
  35. Mak J, Shires D, Prieto L, Ahmedani B, Becerra-Culqui T, Bradlyn A, Flanders W, Getahun D, Giammattei S, Hunkeler E, Lash T, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Slovis J, Tangpricha V, Vupputuri S, Goodman M. “Incidence and Determinants of Suicide Attempts in a Cohort of Transgender and Gender Non-Conforming People.” Am J Prev Med. 2020 Oct;59(4):570-577.
  36.  Antun A, Zhang Q, Bhasin S, Bradlyn A, Flanders W, Getahun D, Lash T, Nash R, Roblin D, Silverberg M, Tangpricha V, Vupputuri S, Goodman M. “Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy.” J Endocr Soc. 2020 Aug 25;4(11):bvaa119.
  37. Greene S, Taylor C, Vupputuri S. “Celebrating a Quarter-Century of Public Domain Research – The 25th Annual Conference of the Health Care Systems Research Network.” J Patient Cent Res Rev. 2019;6:2018-23.
  38. Vupputuri S, Rubenstein KB, Derus A, Loftus B, Horberg M. “Factors Contributing to Racial Disparities in Influenza Vaccinations.” PLoS One. 2019 Apr 3;14(4):e0213972.
  39. Nichols G, Romo-LeTourneau V, Vupputuri S, Thomas S. “Delays in Anti-Hyperglycemic Therapy Initiation and Intensification are Associated with Cardiovascular Events, Heart Failure Hospitalizations, and All-Cause Mortality.” Diabetes Obes Metab. 2019 Mar 3.
  40. Daugherty S, Vupputuri S, Hanratty R, Steiner J, Maertens J, Blair I, Dickinson M, Helmkamp L, Havranek E. “Using Values Affirmation to Reduce the Effects of Stereotype Threat on Hypertension Disparities: Rationale and Design for the Multicenter Randomized HYpertension and VALUEs (HYVALUE) Trial.’ JMIR Res Protoc. 2019 Mar 25;8(3):e12498.
  41. Gerth J, Becerra-Culqui T, Bradlyn A, Getahun D, Hunkeler EM, Lash T, Millman A, Nash R, Quinn V, Robinson B, Roblin D, Silverberg M, Tangpricha V, Vupputuri S, Goodman M. “Agreement between medical records and self-reports: Implications for transgender health research.” Rev Endocr Metab Disord. 2018 Sep 15.
  42. Reboussin D, Allen N, Griswold M, Guallar E, Hong Y, Lackland D, Miller E, Polonsky T, Thompson-Paul A, Vupputuri S. “A Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA /PCNA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.” Hypertension. 2018 Jun;71(6):e116-e135.
  43. Reboussin D, Allen N, Griswold M, Guallar E, Hong Y, Lackland D, Miller E, Polonsky T, Thompson-Paul A, Vupputuri S. “A Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA /PCNA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.” J Am Coll Cardiol. 2018 May 15;71(19):2176-2198.
  44. Reynolds K, Adams K, Boudreau D, Cassidy A, Fortmann S, Go A, Goldberg R, Greenlee R, Gunter M, Gurwitz J, Lieu T, Magid D, McNeal C, Newton K, Novotny R, Quesenberry C, Smith D, Steinhubl S, Tom J, Vupputuri S, Waring SC, Sidney S. “Trends in the Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN), 2000-2008.” Am J Med. 2016 Oct 14.
  45. Wu B, Bell K, Kern D, Tunceli O, Willey V, Vupputuri S, Stanford A, Kalsekar I. “Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012.’ BMJ Open Diabetes Res Care. 2016 Apr 11;4(1)
  46. Smith D, O’Keefe-Rosetti M, Owen-Smith A, Rand C, Tom J, Vupputuri S, Laws R, Waterbury A, Dyson D, Yonehara C, Williams A, Shneider J, Dickerson J, Vollmer W. “Improving Adherence to Cardiovascular Therapies: An Economic Evaluation of a Randomized Pragmatic Trial.” Value Health. 2016 Mar;19(2):176-84.
  47. Vupputuri S, Joski J, Whooley M, Kilpatrick R, Robinson B, Safford M, Yun H, Muntner P. “The Association ofStatin Persistence and Uncontrolled Low-Density Lipid Cholesterol Among Patients at High Risk of Coronary Heart Disease in a Managed Care Organization.” Am J Manag Care. 2016 Mar 1;22(3):e106-15.
  48. Smith D, Johnson E, Adams K, Boudreau D, Cassidy A, Fortmann S, Greenlee R, Gunter M, Gurwitz J, Lieu T, Magid D, McNeal C, Reynolds K, Steinhubl S, Thorp M, Tom J, Vupputuri S, VanWormer J, Weinstein J, Go AS, Sidney S. “Comparative Effectiveness of Statin Therapy in Adults with Chronic Kidney Disease and Acute Myocardial Infarction.” Am J Med. 2015 Jul 10.

 

Current Studies

  1. Social Determinants of Health and Racial/Ethnic Disparities (SO HEARD) in Hypertension, Diabetes, and Chronic Kidney Disease
    Goal:     The overall goal of this project is to conduct an in-depth assessment of racial/ethic differences in hypertension, diabetes, and chronic kidney disease by disentangling the relationship between social determinants of health and race/ethnicity.
    Funder:     Social Needs Network for Evaluation and Translation
    Role: Co-Primary Investigator
  2. Impact of Coronavirus Disease 2019 on Cardiovascular Care: Collateral Damage from a Pandemic
    Goal:     This study examines characteristics of the COVID-19 patient population and factors associated with mortality especially in high-risk subgroups.  Further the project assesses trends in cardiovascular hospitalization rates prior to and during the COVID-19 pandemic.
    Funder:     Garfield Memorial Fund
    Role: Co-Primary Investigator
  3. Cohort Study of Patients with Disorder of Sex Development (DSD)
    Goal:     The goal of this study is to f=develop and validate an electronic health record-based cohort of patients with DSD, across 3 large health systems and describe clinical characteristic and pathways of care.  We will also compare DSD quality of care indicators against actual DSD management delivered.
    Funder:     NICHD
    Role:     Co-Investigator/Site Primary Investigator
  4. Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities
    Goal:     This pragmatic trail examines the effect of intervening on perceived stereotype threat on hypertension management by testing a values affirmation intervention, across 3 diverse health systems.  The primary outcome is change in adherence to antihypertensive therapies with the secondary outcome of change in blood pressure.
    Funder:     NIH/NHLBI
    Role:     Co-Investigator/Site Primary Investigator
  5. HbA1c Variability and Health Outcomes Among Patients with Diabetes
    Goal: The purpose of this study is to develop a new quality measure for patients with diabetes, beyond just HbA1c alone, to better identify those at risk for diabetes complications and mortality.
    Funder:     NIDDK
    Role:     Site Primary Investigator

Recent Presentations

  1. Petito L, Huang X, Jefferson C, Vupputuri S, Lancki N, Shah N, Lloyd-Jones D, Khan S. “Framingham risk and major adverse cardiovascular events among patients with hypertension ineligible for SPRINT.” Submitted to the American Heart Association Scientific Sessions 2024, Chicago, IL
  2. Berry N, Sheu Y, Chesbrough K, Bishop C, Vupputuri S. “Rates and Predictors of Guideline-Directed Medical Therapy Among Patients with Heart Failure with Reduced Ejection Fraction in a Large, Integrated Healthcare System.” HFSA Annual Scientific Meeting, September 2024, Atlanta, GA
  3. Vupputuri S, Kim S, Clennin M, Cromwell L, Daugherty S. “The Contribution of Social Needs Factors to Racial Differences in Type 2 Diabetes.” Presented at the American Diabetes Association 83rd Scientific Sessions (oral presentation), June 2023, San Diego, CA
  4. Vupputuri S, Kim S, Lee C, Gander J, Roblin D, Clennin M, Daugherty S. “The Contribution of Social Needs Factors to Racial Differences in Hypertension.” Presented at the Health Care Systems Research Network Conference, February 2023, Denver, CO
  5. Awidi A, Woreta F, Sabit A, Hu H, Potu N, Devience E, Wang J, Vupputuri S. “Vision Impairment, Social Factors, and Race/Ethnicity (VISOR) Study–Racial/Ethnic Differences in Visual Impairment in Patients with Cataract.” American Society of Cataract and Refractive Surgery Annual Meeting 2023 San Diego, CA
  6. Thomas J, Yishak A, Hu H, Jefferson C, Vupputuri S. “Factors Associated with Outpatient Acute Kidney Injury in Patients with COVID-19.” Presented at Presented at Health Care Systems Research Network Conference, April 2022, Pasadena, CA
  7. Vupputuri S, Rubenstein K, Jefferson C, Khan S. “The Impact of the COVID-19 Pandemic on Cardiovascular Hospitalizations.” Presented at the Health Care Systems Research Network Conference, April 2021 (virtual). J Patient Cent Res Rev. 2021;8:154-217
  8. Vupputuri S, Rubenstein K, Jefferson CR, Khan S. “Racial/Ethnic Differences in Mortality Among Patients With COVID-19.” Presented at Health Care Systems Research Network Conference, April 2021 (virtual). J Patient Cent Res Rev. 2021;8:154-217
  9. Jaberizadeh A, Havranek EP, Helmkamp L, Blair I, Dickinson L, Hanratty R, Maertens J, Steiner J, Vupputuri S, and Daugherty SL. “Comparing core values by patient race in two trials using values affirmation to reduce health disparities. Presented at 2020 SGIM Annual Meeting.
  10. Henderson K, Helmkamp L, Steiner J, Havranek E, Vupputuri S, Hanratty R, Dickinson M, Maertens J, and Daugherty S. “Social Determinants of Health and Participant Retention in a Trial Targeting Racial Disparities in Hypertension: Findings from the Hypertension and Values (HYVALUE) Trial.” Presented at QCOR 2020 Scientific Sessions
  11. Yishak A, Brentari R, Love Lalonde RM, Clark E, Sun J, Vupputuri S. “Timely Referral for Preemptive Listing For Renal Transplant In Those With (eGFR) Of 20 Or Less.” Presented at the American Transplant Congress, June 2019, Boston, MA
  12. Goodman M, Cromwell L, Bradlyn A, Robinson B, Lash T, Getahun D, Im T, Contreras R, Lee P, Roblin D, Vupputuri S, Truong C, Sandberg D. “Identification of Persons with Disorders of Sex Development in Electronic Medical Records: Methodology and Early Results.” Presented at the WPATH 2018 Biennial Symposium, November 2018, Buenes Aires, Argentina
  13. Vupputuri S, Romo-LeTourneau V, Nichols G, Thomas S. “Cumulative Delays in Treatment Intensification over Three Typical Stages of Anti-Hyperglycemic Treatment.” Presented at the American Diabetes Association 78th Scientific Sessions, June 2018, Orlando, Florida.
  14. Nichols G, Romo-LeTourneau V, Vupputuri S, Thomas S. “Delays in Anti-Hyperglycemic Treatment Intensification and Risk of Diabetes Complications.” Presented at the American Diabetes Association 78th Scientific Sessions, June 2018, Orlando, Florida
  15. Truong C, Daugherty S, Hu H, Durfee J, Wain K, Martens J, McCance J, Heyn H, Skenadore A, Wright L, Dirksen S, Hanratty R, Steiner J, Havranek E, Blair I, Vupputuri S. “Assessing Patient Recruitment Strategies by Race in the Multicenter Randomized HYpertension and VALUEs (HYVALUE) Trial.” Abstracts from the 24th annual Health Care Systems Research Network Conference, April 11-13, 2018, Minneapolis, Minnesota. J Patient Cent Res Rev. 2017;5:56-131
  16. Vupputuri S, Boonyasai R, Rubenstein KB, Derus A, Truong C. “Racial Disparities in Hypertension (RADISH): Decomposing the effects of risk factor distribution and risk factor impact on racial disparities.” Abstracts from the 24th annual Health Care Systems Research Network Conference, April 11-13, 2018, Minneapolis, Minnesota. J Patient Cent Res Rev. 2017;5:56-131
  17. Vupputuri S, Truong C, Wells A, Derus AJ, Emanuel EW. “The Transgender Response and Quality of Care Study at KP Mid-Atlantic States (TRAQC-KPMAS): Patient Focus Groups.” Abstracts from the 24th annual Health Care Systems Research Network Conference, April 11-13, 2018, Minneapolis, Minnesota. J Patient Cent Res Rev. 2017;5:56-131
  18. Vupputuri S, Derus AJ, Truong C, Wells A, Emanuel EW. “The Transgender Response and Quality of Care Study at KP Mid-Atlantic States (TRAQC-KPMAS): Data Quality Metrics.” Abstracts from the 24th annual Health Care Systems Research Network Conference, April 11-13, 2018, Minneapolis, Minnesota. J Patient Cent Res Rev. 2017;5:56-131
  19. Yishak A, Clark E, Sun J, Rubenstein K, Vupputuri S. Early Referral Increases Pre-Emptive Kidney Transplant (PKT). Presented at the ISN World Congress of Nephrology 2017, April 2017, Mexico City, Mexico
  20. Derus AJ, Rubenstein K, Vupputuri S. “Geographic Disparities in Influenza Vaccination Among Patients at Kaiser Permanente Mid-Atlantic States, 2014-2015.” Presented at Health Care Systems Research Network Conference, April 2016, Atlanta, GA
  21. Wu B, Bell K, Kern D, Tunceli O, Willey V, Vupputuri S, Stanford A, Kalsekar I. “Temporal Trend and Prevalence of CKD Stages (KDIGO 2012) in US Adults with Type 2 Diabetes Mellitus and Demographic Subgroups: NHANES 2007-2012.” Presented at the International Society of Pharmacoeconomics and Outcomes Research 20th Annual International Meeting, May 16-20, 2015, Philadelphia, PA
  22. Wu B, Bell K, Kern DM, Tunceli O, Willey V, Vupputuri S, Stanford A, Kalsekar I. “Potential Risk Factors Associated with the Presence and Severity of CKD in US Adults with T2DM: NHANES 2007-2012.” Presented at the American Diabetes Association 75th Scientific Sessions, June 5-9, 2015, Boston, MA
  23. Wu B, Bell K, Kern D, Tunceli O, Willey V, Vupputuri S, Stanford A, Kalsekar I. “Prescribing Patterns of Antidiabetic and Antihypertensive Agents by KDIGO 2012 Chronic Kidney Disease Stages in US Adults with Type 2 Diabetes Mellitus: NHANES 2007-2010.” Presented at the Academy of Managed Care Pharmacy 27th Annual Meeting and Expo April 7-10, 2015, San Diego, CA
Back To Top